drugset / Trial / NCT01500707

Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)

NCT01500707 ↗

Phase 1 Withdrawn Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelTreatment

Summary

This study is being done to assess the pharmacokinetics of SCH 900800 in participants with moderate to severe Parkinson's Disease (PD) being treated with L-DOPA.

Timeline

Start
2013-01
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject SCH 900800 Unknown 20 mg Oral

Indications